Paper31270690
Influence of recurrent vulvovaginal candidiasis on quality of life issues.
Fukazawa EI and 5 others. Arch Gynecol Obstet, 2019. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Influence of recurrent vulvovaginal candidiasis on quality of life issues. Papers, record 31270690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31270690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Candidiasis, Vulvovaginal | Major topic |
| Health Status | Major topic |
| Quality of Life | Major topic |
| Adult | |
| Candida | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Recurrence | |
| Sexual Behavior | |
| Surveys and Questionnaires |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889144 | Management of Recurrent Vaginitis. | Curr Obstet Gynecol Rep | 2026 | https://conductscience.org/library/papers/42889144 | PubMed |
| 42768343 | Latent profile analysis of stigma and medical coping among patients with vaginitis: a cross-sectional study. | BMC Womens Health | 2026 | https://conductscience.org/library/papers/42768343 | PubMed |
| 42646089 | Nanomedicine in the Topical Management of Vulvovaginal Candidiasis: An Overview of In Vivo Data. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42646089 | PubMed |
| 41836010 | Ketoprofen-loaded quatsomes as a smart repurposed antifungal therapy for vaginal infections: formulation, characterization, and microbiological evaluation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41836010 | PubMed |
| 41420368 | Attending to Gyn-Ecology: Managing the 'Mess' of Recurrent Vulvovaginal Thrush. | Sociol Health Illn | 2026 | https://conductscience.org/library/papers/41420368 | PubMed |
| 41078368 | Study on the impact of biofilm formation by Candida albicans in recurrent vulvovaginal candidiasis on drug susceptibility. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41078368 | PubMed |
| 41024984 | Discovering a new paradigm: Gut microbiota as a central modulator of sexual health. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/41024984 | PubMed |
| 40944040 | The Impact of Gynecological Pathologies on Patients' Quality of Life from Menarche to Menopause-Literature Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40944040 | PubMed |
| 40136919 | Improving Vaginal Health with a Zinc-Containing Vaginal Hydrogel. | Gels | 2025 | https://conductscience.org/library/papers/40136919 | PubMed |
| 39514006 | Integrating Clinical and Microbiological Expertise to Improve Vaginal Candidiasis Management. | Mycopathologia | 2024 | https://conductscience.org/library/papers/39514006 | PubMed |
| 39149209 | Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39149209 | PubMed |
| 38514673 | Invasive candidiasis. | Nat Rev Dis Primers | 2024 | https://conductscience.org/library/papers/38514673 | PubMed |
| 38463778 | Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection. | Heliyon | 2024 | https://conductscience.org/library/papers/38463778 | PubMed |
| 38099456 | Psychosocial impact of recurrent urogenital infections: a review. | Womens Health (Lond) | 2023 | https://conductscience.org/library/papers/38099456 | PubMed |
| 36899343 | Candidiasis profile at the outpatient department of the university of cape coast hospital in the central region of Ghana: a retrospective study. | BMC Womens Health | 2023 | https://conductscience.org/library/papers/36899343 | PubMed |
| 36159646 | Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36159646 | PubMed |
| 36123738 | Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey. | BMC Womens Health | 2022 | https://conductscience.org/library/papers/36123738 | PubMed |
| 36105548 | Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis. | SAGE Open Med | 2022 | https://conductscience.org/library/papers/36105548 | PubMed |
| 35711520 | Antifungal Activities of Phytochemically Characterized Hydroethanolic Extracts of Sclerocarya birrea Leaves and Stem Bark against Fluconazole-Resistant Candida albicans Strains. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35711520 | PubMed |
| 35371482 | Vulvovaginal candidiasis: A real-world evidence study of the perceived benefits of Canesten®. | SAGE Open Med | 2022 | https://conductscience.org/library/papers/35371482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31270690
GET https://conductscience.org/api/papers/v1/31270690/cited_by?page=2